Surmounting withdrawal to initiate fast treatment with naltrexone (CTN-0097). DSC5 contract. 09/20/2019 - 11/23/2021. N01DA-19-2250.
Ended Awarded Last action
- Contract number
- 75N95019F00093
- Awardee
-
The Emmes Company, LLC UEI NBQCBJ6FXBU4
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,251,569
Award facts
- Opportunity
-
- 75N95019R00016 Solicitation number
- Contract value 100% obligated
- $1,251,569.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Change Order | $0 | |
| Original award | $1,251,569 |
About this award
The National Institute on Drug Abuse awarded a $1.25 million delivery order contract to The Emmes Company LLC under its Data, Statistics, and Clinical Trial Support Center indefinite delivery/indefinite quantity contract vehicle. The cost plus fixed fee contract is for the Surmounting Withdrawal to Initiate Fast Treatment with Naltrexone clinical trial and will run from September 2019 through April 2023. As the prime contractor, The Emmes Company will provide data management, biostatistical analysis, and clinical trial support services for the randomized controlled trial evaluating the effectiveness of different naltrexone induction strategies in treating opioid use disorder. The funding agency, the National Institutes of Health within the Department of Health and Human Services, supports research on drug abuse and addiction through NIDA's clinical trials, epidemiological studies, and behavioral research programs.
Quick answers
Who was awarded contract 75N95019F00093?
75N95019F00093 was awarded to The Emmes Company, LLC by National Institute on Drug Abuse (National Institutes of Health) on September 20, 2019.
How much is contract 75N95019F00093 worth?
The government has obligated $1,251,569 on 75N95019F00093.
Is contract 75N95019F00093 an order under another contract?
Yes. 75N95019F00093 is a delivery order under 75N95019D00013, an indefinite delivery contract.
Was contract 75N95019F00093 competed?
The extent of competition for 75N95019F00093 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award